Lucid Diagnostics Inc.
LUCD
$1.16
$0.021.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.29M | -55.26M | -61.83M | -45.53M | -44.82M |
| Total Depreciation and Amortization | 885.00K | 880.00K | 887.00K | 1.17M | 1.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.43M | 12.57M | 19.40M | 4.65M | 4.58M |
| Change in Net Operating Assets | -1.81M | -1.25M | -2.46M | -4.43M | -5.59M |
| Cash from Operations | -43.78M | -43.06M | -43.99M | -44.14M | -44.25M |
| Capital Expenditure | -405.00K | -377.00K | -352.00K | -296.00K | -212.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -350.00K | -350.00K | -350.00K | -350.00K |
| Cash from Investing | -405.00K | -727.00K | -702.00K | -646.00K | -562.00K |
| Total Debt Issued | 21.98M | 21.98M | 21.98M | 21.62M | 0.00 |
| Total Debt Repaid | -3.62M | -3.62M | -3.62M | -3.62M | -- |
| Issuance of Common Stock | 58.67M | 31.63M | 15.17M | 451.00K | 451.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 11.63M | 29.80M | 34.80M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.03M | 49.99M | 45.16M | 48.25M | 35.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.84M | 6.20M | 469.00K | 3.46M | -9.56M |